Our study adds to this literature by assessing the independent relationships between WMH and CSF Aβ1-42 and tau at baseline and brain volume losses over the following year in 3 diagnostic groups representing the range in clinical status from normal ageing to AD. This evidence concerns the gene MAPT and Alzheimer disease.